KARINA FELIZ: Open Payments
NPI 1336911460 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 86 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $2,364 · 2025 $1,753
Food & beverage: $1,753
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $362 |
| ABBVIE INC. | 14 | $295 |
| Corium, LLC | 13 | $274 |
| Alkermes, Inc. | 11 | $264 |
| Teva Pharmaceuticals USA, Inc. | 4 | $86 |
| Neurocrine BioSciences, Inc. | 4 | $84 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Almatica Pharma LLC | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
Products named: CAPLYTA, VRAYLAR, Azstarys, ARISTADA, AUSTEDO XR, INGREZZA, Auvelity, LOREEV XR.
Industry payments across AL — which companies pay providers there.
